ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib

por Romero, Atocha, Serna-Blasco, Roberto, Alfaro, Cristina, Sánchez-Herrero, Estela, Barquín, Miguel, Turpin, María Carmen, Chico, Sofía, Sanz-Moreno, Sandra, Rodrigez-Festa, Alejandro, Laza-Briviesca, Raquel, Cruz-Bermudez, Alberto, Calvo, Virginia, Royuela, Ana, Provencio, Mariano
Publicado 2020

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

por Sánchez‐Herrero, Estela, Serna‐Blasco, Roberto, Ivanchuk, Vadym, García‐Campelo, Rosario, Dómine Gómez, Manuel, Sánchez, José M., Massutí, Bartomeu, Reguart, Noemi, Camps, Carlos, Sanz‐Moreno, Sandra, Calabuig‐Fariñas, Silvia, Jantus‐Lewintre, Eloísa, Arnal, Magdalena, Fernández‐Orth, Dietmar, Calvo, Virginia, González‐Rumayor, Víctor, Provencio, Mariano, Romero, Atocha
Publicado 2021

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation

por Serna-Blasco, Roberto, Sánchez-Herrero, Estela, Robado de Lope, Lucía, Sanz-Moreno, Sandra, Rodríguez-Festa, Alejandro, Ares-Trotta, Dunixe, Cruz-Bermúdez, Alberto, Franco, Fabio, Sánchez-Hernández, Alfredo, Campayo, María de Julián, García-Girón, Carlos, Dómine, Manuel, Blasco, Ana, Sánchez, José M., Oramas, Juana, Bosch-Barrera, Joaquim, Sala, María Á., Sereno, María, Romero, Atocha, Provencio, Mariano
Publicado 2022